市場調查報告書

經肺藥物給藥 (藥物輸送)的全球市場分析、預測 (2019-2029年)

Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

出版商 Visiongain Ltd 商品編碼 886830
出版日期 內容資訊 英文 155 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
經肺藥物給藥 (藥物輸送)的全球市場分析、預測 (2019-2029年) Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029
出版日期: 2019年05月29日內容資訊: 英文 155 Pages
簡介

全球經肺藥物給藥 (藥物輸送)的市場將從2018年的406億7000美元,在預測期間中以7.60%的年複合成長率 (CAGR) 成長。慢性呼吸疾病罹患率、盛行率的增加預計促進該市場的成長。

本報告提供全球經肺藥物給藥 (藥物輸送)的市場調查,經肺藥物給藥概要,作用、功能,優點及缺點,市場成長的各種影響因素分析,各劑型、設備類型、罐類型、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 簡介:經肺藥物給藥 (藥物輸送)

  • 所謂經肺藥物給藥
  • 經肺藥物給藥所扮演的角色、功能
  • 經肺藥物給藥的優點及缺點
  • 經肺藥物給藥設備的各種類型
    • 定量噴霧吸入器 (MDI)
    • 乾粉吸入劑 (DPI)
    • 噴霧器
  • 經肺藥物給藥的機制
  • 呼吸系統疾病的盛行率

第3章 全球市場分析、預測

  • 市場概要
  • 全球經肺藥物給藥市場
  • 銷售額預測
  • 市場佔有率的預測:各地區

第4章 定性分析

  • 市場成長的促進因素
  • 市場成長的阻礙因素
  • 市場趨勢
  • 波特的五力分析

第5章 市場分析、預測:各產品

  • 市場概要
  • 市場預測
  • 市場佔有率
    • 劑型
      • 懸浮液氣霧劑
      • 溶液氣霧劑
      • 乾粉
    • 設備
      • 定量噴霧吸入器 (MDI)
      • 乾粉吸入劑 (DPI)
      • 噴霧器
      • 設備

第6章 市場分析、預測:各罐類型

  • 市場預測
    • 平面罐
    • 塗層罐

第7章 市場分析、預測:各用途

  • 市場預測
    • 氣喘
    • 慢性阻塞性肺病 (COPD)
    • 囊狀纖維化症
    • 其他

第8章 市場分析、預測:各終端用戶

  • 市場概要
  • 市場預測
  • 市場佔有率
    • 醫院、診療所
    • 居家照護

第9章 市場分析、預測:各地區、主要國家

  • 市場預測
  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 主要企業

  • GlaxoSmithKline PLC
  • Philips Respironics
  • Boehringer Ingelheim GmbH
  • 3M Health Care
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceuticals
  • 其他主要企業

第11章 總論

  • 市場展望
  • 主要調查結果
目錄
Product Code: PHA0371

The global pulmonary/respiratory drug delivery market reached $40.67 bn in 2018 and is expected to grow at a CAGR of 7.60% in 2019-2024. The MDIs segment is estimated to hold a share of 62.4% in 2018. Increasing prevalence and incidence of chronic respiratory diseases is a major factor that is expected to drive the growth of this market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 155-page report you will receive 70 tables and 84 figures- all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global pulmonary/respiratory drug delivery market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Product:

  • Formulation: Suspension Aerosol. Solution Aerosol, Dry Powder Formulation
  • Devices: Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Canister Type:

  • Plain Canisters
  • Coated Canister

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Application:

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Other Applications

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by End-User:

  • Hospitals & Clinics
  • Homecare Settings

Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2018-2029 by regional and national market:

  • North America (US, Canada)
  • Europe (Germany, UK, France, Italy, Spain)
  • Asia-Pacific (Japan, China, India, Australia, Malaysia)
  • RoW (Brazil, Mexico, Turkey, South Africa, Argentina)

Profiles of the selected leading companies:

  • 3M Health Care
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Philips Respironics
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical

Qualitative analysis of the global pulmonary/respiratory drug delivery market. Discussion on trends, factors that drive and restrain the market as well as Porter's Five Forces Analysis.

Key Questions Answered by this Report:

  • What are the global revenue prospects for the period 2018 to 2029?
  • What are the leading national market potentials from 2018 to 2029?
  • How is the respiratory drug delivery market evolving?
  • What is driving and restraining the respiratory drug delivery market?
  • What are the market shares of each segment of the overall respiratory drug delivery market?
  • How will main respiratory drug delivery submarket segments develop over the forecast period and how much revenue will these submarkets account for in 2029?
  • How will the market shares for each respiratory drug delivery submarket develop from 2018 to 2029?
  • What will be the main commercial drivers for the market from 2018 to 2029?
  • How will political and regulatory factors influence that industry and its submarkets?
  • How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?

Visiongain's study is intended for anyone requiring commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market. You find data, trends and predictions.

Buy our report today Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029: Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Global Respiratory Drug Delivery Market Overview
  • 1.2 Global Respiratory Drug Delivery Market Segmentation
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Why You Should Read This Report
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Who is This Report For?
  • 1.8 Methods of the Study
  • 1.9 Frequently Asked Questions (FAQ)
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to Respiratory Drug Delivery

  • 2.1 What is Respiratory Drug Delivery?
  • 2.2 The Role and Function of Pulmonary/Respiratory Drug Delivery
  • 2.3 Advantages of Respiratory Drug Delivery
  • 2.4 Disadvantages of Respiratory Drug Delivery
  • 2.5 Type of Respiratory Drug Delivery Devices
    • 2.5.1 Metered Dose Inhalers (MDI)
    • 2.5.2 Dry Powder Inhalers
    • 2.5.3 Nebulizer
  • 2.6 Mechanisms of Pulmonary Drug Administration
  • 2.7 Prevalence of Respiratory Diseases?

3. Respiratory Drug Delivery: World Market 2019-2029

  • 3.1 Respiratory Drug Delivery Market Overview, 2018
  • 3.2 The World Respiratory Drug Delivery Market
  • 3.3 World Respiratory Drug Delivery Market: Sales Forecast 2019-2029
  • 3.4 Changing Market Shares by Region 2018-2029

4. Respiratory Drug Delivery: Qualitative Analysis 2019-2029

  • 4.1 Respiratory Drug Delivery Market: Drivers 2019-2029
    • 4.1.1 Increase in Prevalence and Incidence of Respiratory Diseases
    • 4.1.2 Technological Advancements
    • 4.1.3 Growing Support of Government and NGOs for Respiratory Diseases Healthcare Awareness
  • 4.2 Respiratory Drug Delivery Market Restraints: 2019-2029
    • 4.2.1 Stringent Government Regulations
    • 4.2.2 Intense Competition Among Vendors
  • 4.3 Respiratory Drug Delivery Market Trends: 2019-2029
    • 4.3.1 Introduction of Smart/Digital Inhalers
    • 4.3.2 Recent Advances in Pulmonary Drug Delivery
    • 4.3.3 Trends in MDI Technology
    • 4.3.4 Trends in DPI Technology
  • 4.4 Respiratory Drug Delivery Market: Porters Five Forces Analysis, 2019-2029
    • 4.4.1 Bargaining Power of Supplier: Moderate
    • 4.4.2 Bargaining Power of Buyer: Moderate
    • 4.4.3 Competitive Rivalry: High
    • 4.4.4 The Threat of New Entrants: Moderate
    • 4.4.5 Threat of Substitutes: Moderate

5. Respiratory Drug Delivery Market by Product, 2019-2029

  • 5.1 Market Overview
  • 5.2 Global Respiratory Drug Delivery Market Forecast by Product, 2019-2029
  • 5.3 Market Share of Respiratory Drug Delivery by Product
    • 5.3.1 Formulation: Market Forecast, 2019-2029
    • 5.3.2 Suspension Aerosol: Market Forecast, 2019-2029
    • 5.3.3 Solution Aerosol: Market Forecast, 2019-2029
    • 5.3.4 Dry Powder Formulation: Market Forecast, 2018-2029
    • 5.3.5 Devices: Market Forecast, 2018-2029
    • 5.3.6 Metered Dose Inhalers (MDIs): Market Forecast, 2019-2029
    • 5.3.7 Dry Powder Inhalers (DPIs): Market Forecast, 2019-2029
    • 5.3.8 Nebulizers: Market Forecast, 2019-2029
    • 5.3.9 Accessories: Market Forecast, 2019-2029

6. Respiratory Drug Delivery Market by Canister Type, 2019-2029

  • 6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type, 2019-2029
  • 6.2 Market Forecast 2019-2029
  • 6.3 Plain Canisters Market
  • 6.4 Coated Canister Market

7. Respiratory Drug Delivery Market by Application, 2019-2029

  • 7.1 Global Respiratory Drug Delivery Market Forecast by Application, 2019-2029
  • 7.2 Market Forecast 2019-2029
  • 7.3 Asthma Market
  • 7.4 Chronic Obstructive Pulmonary Disease (COPD) Market
  • 7.5 Cystic Fibrosis Market
  • 7.6 Other Applications Market

8. Respiratory Drug Delivery Market by End-User 2019-2029

  • 8.1 Market Overview
  • 8.2 Global Respiratory Drug Delivery Market Forecast by End-User, 2019-2029
  • 8.3 Market Share of Respiratory Drug Delivery by End-User
  • 8.4 Hospitals & Clinics Market
  • 8.5 Homecare Settings Market

9. Leading National Markets 2019-2029

  • 9.1 Geographical Breakdown of the World Respiratory Drug Delivery Market
  • 9.2 Global Respiratory Drug Delivery Market: Regional Forecast 2019-2029
  • 9.3 How Will Regional Market Shares Change to 2029?
  • 9.4 North America Respiratory Drug Delivery Market, 2019-2029
    • 9.4.1 US Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.4.2 Canada Respiratory Drug Delivery Market Forecast 2019-2029
  • 9.5 Europe Respiratory Drug Delivery Market, 2019-2029
    • 9.5.1 Europe Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.5.2 Germany Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.5.3 UK Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.5.4 French Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.5.5 Italian Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.5.6 Spanish Respiratory Drug Delivery Market Forecast 2019-2029
  • 9.6 Asia-Pacific Respiratory Drug Delivery Market 2019-2029
    • 9.6.1 Japanese Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.6.2 Chinese Respiratory Drug Delivery Market 2019-2029
    • 9.6.3 Indian Respiratory Drug Delivery Market 2019-2029
    • 9.6.4 Australia Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.6.5 Malaysia Respiratory Drug Delivery Market Forecast 2019-2029
  • 9.7 RoW Respiratory Drug Delivery Market 2019-2029
    • 9.7.1 Brazilian Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.7.2 Mexico Respiratory Drug Delivery Market 2019-2029
    • 9.7.3 Turkey Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.7.4 South Africa Respiratory Drug Delivery Market Forecast 2019-2029
    • 9.7.5 Argentina Respiratory Drug Delivery Market Forecast 2019-2029

10. Leading Companies in the Respiratory Drug Delivery Market

  • 10.1 GlaxoSmithKline PLC
    • 10.1.1 Product Portfolio
    • 10.1.2 Financial Overview
  • 10.2 Philips Respironics
    • 10.2.1 Product Portfolio
    • 10.2.2 Financial Overview
  • 10.3 Boehringer Ingelheim GmbH
    • 10.3.1 Products Portfolio
    • 10.3.2 Financial Overview
    • 10.3.3 Recent Developments
  • 10.4 3M Health Care
    • 10.4.1 Product Portfolio
    • 10.4.1 Financial Overview
  • 10.5 AstraZeneca plc
    • 10.5.1 Product Portfolio
    • 10.5.2 Financial Overview
    • 10.5.3 Recent Developments
  • 10.6 Merck & Co., Inc.
    • 10.6.1 Product Portfolio
    • 10.6.2 Financial Overview
  • 10.7 Novartis AG
    • 10.7.1 Products Portfolio
    • 10.7.2 Financial Overview
    • 10.7.3 Recent Developments
  • 10.8 Omron Corporation
    • 10.8.1 Product Portfolio
    • 10.8.2 Financial Overview
  • 10.9 Sunovion Pharmaceuticals Inc.
    • 10.9.1 Product Portfolio
    • 10.9.2 Financial Overview
    • 10.9.3 Recent Developments
  • 10.10 Teva Pharmaceuticals
    • 10.10.1 Product Portfolio
    • 10.10.2 Financial Overview
    • 10.10.3 Recent Developments
  • 10.11 Other Prominent Players in the Market

11. Conclusion

  • 11.1 Outlook for Pulmonary/respiratory drug delivery Market
  • 11.2 Key Findings

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 3.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.1 Global Respiratory Drug Delivery Market Forecast by Product: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 5.2 Global Formulation Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.3 Global Suspension Aerosol Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.4 Global Solution Aerosol Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.5 Global Dry Powder Formulation Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.6 Global Respiratory Drug Delivery Devices Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.7 Global Metered Dose Inhalers (MDIs) Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.8 Global Dry Powder Inhalers (DPIs) Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.9 Global Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.10 Global Jet Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.11 Global Ultrasonic Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.12 Global Soft Mist Nebulizers Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 5.13 Global Accessories Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 6.2 Global Plain Canisters Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 6.3 Global Coated Canisters Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.1 Global Respiratory Drug Delivery Market Forecast by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 7.2 Global Asthma Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.3 Global COPD Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.4 Global Cystic Fibrosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 7.5 Global Other Applications Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 8.1 Global Respiratory Drug Delivery Market Forecast by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 8.2 Global Hospitals & Clinics Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 8.3 Global Homecare Settings Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2018-2029
  • Table 9.1 World Respiratory Drug Delivery Market by Region: Revenue ($bn) and Market Share (%) 2018 and 2029
  • Table 9.2 Global Respiratory Drug Delivery Market Forecast by Region: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.3 North America Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.4 North America Respiratory Drug Delivery Market by Region Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.5 US Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.6 Canada Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.7 Europe Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.8 Europe Respiratory Drug Delivery Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.9 Germany Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.10 UK Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.11 French Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.12 Italian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.13 Spanish Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.14 Asia-Pacific Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.15 Asia-Pacific Respiratory Drug Delivery Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.16 Japanese Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.17 Chinese Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.18 Indian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.19 Australia Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.20 Malaysia Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.21 Brazilian Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.22 Mexico Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.23 Turkey Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.24 South Africa Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.25 Argentina Respiratory Drug Delivery Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 10.1 Overview: GlaxoSmithKline plc.
  • Table 10.2 Product Portfolio: GlaxoSmithKline plc.
  • Table 10.3 Overview: Philips Respironics
  • Table 10.4 Product Portfolio: Philips Respironics
  • Table 10.5 Overview: Boehringer Ingelheim GmbH
  • Table 10.6 Product Portfolio: Boehringer Ingelheim GmbH
  • Table 10.7 Overview: 3M Health Care
  • Table 10.8 Product Portfolio: 3M Health Care
  • Table 10.9 Overview: AstraZeneca plc
  • Table 10.10 Product Portfolio: AstraZeneca
  • Table 10.11 Overview: Merck & Co., Inc
  • Table 10.12 Product Portfolio: Merck & Co., Inc
  • Table 10.13 Overview: Novartis
  • Table 10.14 Product Portfolio: Novartis
  • Table 10.15 Overview: OMRON Corporation
  • Table 10.16 Product Portfolio: Omron Corporation
  • Table 10.17 Overview: Sunovion Pharmaceuticals
  • Table 10.18 Product Portfolio: Sunovion Pharmaceuticals Inc.
  • Table 10.19 Overview: Teva Pharmaceuticals
  • Table 10.20 Product Portfolio: Teva Pharmaceuticals

List of Figures

  • Figure 1.1 Global Respiratory Drug Delivery Market Segmentation Overview, 2018
  • Figure 2.1 Types of Respiratory Drug Delivery Devices, 2018
  • Figure 3.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%) 2018-2029
  • Figure 3.2 Global Respiratory Drug Delivery Market Forecast Share (%) by Region 2018-2029
  • Figure 4.1 Respiratory Drug Delivery Market: Drivers 2019-2029
  • Figure 4.2 Respiratory Drug Delivery Market: Restraints 2019-2029
  • Figure 4.3 Respiratory Drug Delivery Market: Trends 2019-2029
  • Figure 5.1 Global Respiratory Drug Delivery Market Forecast by Product: Revenue ($bn) 2018-2029
  • Figure 5.2 Global Respiratory Drug Delivery Market Forecast by Product: Market Share (%) 2018-2029
  • Figure 5.3 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2018
  • Figure 5.4 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2024
  • Figure 5.5 Global Respiratory Drug Delivery Market Forecast by Product: Market Shares (%), 2029
  • Figure 5.6 Global Formulation Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.7 Global Suspension Aerosol Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.8 Global Solution Aerosol Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.9 Global Dry Powder Formulation Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.10 Global Respiratory Drug Delivery Devices Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.11 Global Metered Dose Inhalers (MDIs) Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.12 Global Dry Powder Inhalers (DPIs) Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.13 Global Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.14 Global Jet Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.15 Global Ultrasonic Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.16 Global Soft Mist Nebulizers Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.17 Global Accessories Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 6.1 Global Respiratory Drug Delivery Market Forecast by Canister Type: Revenue ($bn) 2018-2029
  • Figure 6.2 Global Respiratory Drug Delivery Market Forecast by Canister Type: Market Share (%) 2018-2029
  • Figure 6.3 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2018
  • Figure 6.4 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2024
  • Figure 6.5 Global Respiratory Drug Delivery Market by Canister Type: Market Shares (%), 2029
  • Figure 6.6 Global Plain Canisters Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 6.7 Global Coated Canisters Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 7.1 Global Respiratory Drug Delivery Market Forecast by Application: Revenue ($bn) 2018-2029
  • Figure 7.2 Global Respiratory Drug Delivery Market Forecast by Application: Market Share (%) 2018-2029
  • Figure 7.3 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2018
  • Figure 7.4 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2024
  • Figure 7.5 Global Respiratory Drug Delivery Market by Application: Market Shares (%), 2029
  • Figure 7.6 Global Asthma Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 7.7 Global COPD Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 7.8 Global Cystic Fibrosis Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 7.9 Global Other Applications Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 8.1 Global Respiratory Drug Delivery Market Forecast by End-User Market Revenue ($bn) 2018-2029
  • Figure 8.2 Global Respiratory Drug Delivery Market Forecast by End-User Market Share (%) 2018-2029
  • Figure 8.3 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2018
  • Figure 8.4 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2024
  • Figure 8.5 Global Respiratory Drug Delivery Market Forecast by End-User: Market Shares (%), 2029
  • Figure 8.6 Global Hospitals & Clinics Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 8.7 Global Homecare Settings Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.1 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2018
  • Figure 9.2 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2024
  • Figure 9.3 Global Respiratory Drug Delivery Market by Region: Revenues (%), 2029
  • Figure 9.4 North America Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.5 North America Respiratory Drug Delivery Market by Region Forecast: Market Share (%), 2018-2029
  • Figure 9.6 US Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.7 Canada Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.8 Europe Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.9 Europe Respiratory Drug Delivery Market by Country: Revenue ($bn), 2018-2029
  • Figure 9.10 Europe Respiratory Drug Delivery Market by Country: Share (%), 2018-2029
  • Figure 9.11 Germany Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.12 UK Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.13 French Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.14 Italian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.15 Spanish Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.16 Asia-Pacific Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.17 Asia-Pacific Respiratory Drug Delivery Market by Country: Revenue ($bn), 2018-2029
  • Figure 9.18 Asia Pacific Respiratory Drug Delivery Market by Country: Share (%), 2018-2029
  • Figure 9.19 Japanese Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.20 Chinese Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.21 Indian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.22 Australia Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.23 Malaysia Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.24 Brazilian Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.25 Mexico Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.26 Turkey Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.27 South Africa Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 9.28 Argentina Respiratory Drug Delivery Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 10.1 GlaxoSmithKline plc.: Financial Overview, 2016-2018
  • Figure 10.2 Boehringer Ingelheim GmbH: Financial Overview: 2016-2018
  • Figure 10.3 3M Health Care Financial Overview:2018
  • Figure 10.4 AstraZeneca plc: Financial Overview 2016- 2018
  • Figure 10.5 Merck & Co., Inc: Financial Overview 2016-2018
  • Figure 10.6 Novartis: Financial Overview 2016-2018
  • Figure 10.7 OMRON Corporation: Financial Overview 2016-2018
  • Figure 11.1 Global Respiratory Drug Delivery Market Forecast Revenue ($bn), AGR (%) 2018-2029
  • Figure 11.2 Global Respiratory Drug Delivery Market Forecast Share (%) by Region 2018-2029

COMPANIES LISTED:

  • 3M Health Care
  • Adherium
  • Allied Healthcare Products, Inc.
  • Amgen Inc.
  • Aptar Pharma
  • Asthma Australia
  • Asthma UK
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Boehringer Ingelheim Zentrale GmbH
  • CareFusion Corporation
  • Centers for Disease Control and Prevention (CDC)
  • Cipla Ltd
  • Food and Drug Administration (FDA)
  • GF Health Products Inc.
  • GlaxoSmithKline
  • Health Canada
  • Ikaria Australia Pty Ltd
  • Lung Foundation
  • Mallinckrodt
  • Mallinckrodt Canada ULC
  • Mallinckrodt International Holdings S.a r.l.
  • Merck & Co.
  • National Asthma Council
  • NIH
  • Novartis AG
  • OMRON Corporation
  • Omron Healthcare, Inc.
  • OMRON Tateisi Electronics Co.
  • PARI Respiratory Equipment, Inc.
  • Philips Holding USA Inc.
  • Philips Respironics, Inc.
  • Propeller Health
  • Qualcomm Incorporated
  • Qualcomm Life, Inc.
  • Respironics Inc.
  • Sepracor Inc.
  • Siamab Therapeutics, Inc.
  • Sumitomo Dainippon Pharma America, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceuticals
  • Through Treo Solutions LLC
  • World Health Organization (WHO)
Back to Top